Table 3.
Amino Acid Substitutions Observed in the Partial TOSV Nucleocapsid Protein
| 81 | 89 | 93 | 95 | 100 | 101 | 103 | 113 | 121 | 125 | 129 | 133 | 136 | 141 | 146 | 162 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N206.Turkey | P | A | S | Y | G | T | G | S | V | R | E | V | T | I | Y | D |
| N41.Turkey | P | A | S | S | G | N | G | S | V | R | E | V | T | I | Y | D |
| N5A.Turkey | S | A | S | S | G | N | G | S | V | R | E | V | T | I | Y | D |
| N12.Turkey | S | A | S | Y | E | N | G | S | V | R | E | V | T | I | Y | D |
| N40.Turkey | — | — | — | — | G | N | G | S | V | R | E | V | T | I | Y | D |
| PU3.Turkey | — | — | — | — | — | — | G | S | V | R | E | V | T | I | Y | D |
| N9.Turkey | — | — | — | — | — | — | — | S | V | R | E | V | T | I | F | D |
| N8.Turkey | — | — | — | — | — | — | — | S | V | R | E | V | T | I | Y | D |
| N30.Turkey | — | — | — | — | — | — | — | S | V | R | E | V | T | I | Y | D |
| N6A.Turkey | — | — | — | — | — | — | — | S | V | R | E | V | T | I | Y | D |
| N7.Turkey | — | — | — | — | — | — | — | S | V | C | E | V | T | I | F | D |
| N119.Turkey | — | — | — | — | — | — | — | S | V | R | E | V | T | I | Y | D |
| N28.Turkey | — | — | — | — | — | — | — | S | V | R | E | V | T | I | Y | D |
| N20.Turkey | — | — | — | — | — | — | — | P | V | R | E | V | T | I | Y | D |
| N48.Turkey | — | — | — | — | — | — | — | S | V | R | E | I | T | I | Y | D |
| N4A.Turkey | — | — | — | — | — | — | — | P | V | R | E | V | T | I | Y | D |
| N13.Turkey | — | — | — | — | — | — | — | — | V | R | E | V | T | I | Y | D |
| N27.Turkey | — | — | — | — | — | — | — | — | V | R | E | V | T | I | Y | D |
| N90.Turkey | — | — | — | — | — | — | — | — | V | R | E | V | T | I | Y | D |
| Ank2012.Turkey | — | — | — | — | — | — | — | — | V | R | E | V | T | I | Y | D |
| Thr2012.Turkey | — | — | — | — | — | — | — | — | V | R | E | V | T | I | Y | D |
| KE.4.Turkey | — | — | — | — | — | — | C | S | V | R | E | V | T | I | Y | — |
| TOSV/Firenze.ITA/1983/2 | S | A | S | Y | G | N | G | S | V | R | E | V | T | I | Y | D |
| 1500590.France | S | A | S | Y | E | N | G | S | V | R | E | V | T | I | Y | D |
| MRS2010-4319501.France | S | A | S | Y | G | N | G | S | V | R | E | V | T | I | Y | H |
| EsPhGR40.Spain | S | A | S | Y | G | N | G | S | V | R | E | V | T | I | Y | D |
| T8-09.Croatia | S | S | A | Y | G | N | G | S | I | R | G | V | S | V | Y | D |
Viral sequences are designated by strain name and country of origin. Positions are given according to the alignment of the complete nucleocapsid protein of TOSV genotype A strain, TOSV/Firenze.ITA/1983/2 (GenBank accession AIQ84538). All other virus genotypes, strains with higher similarity on the nucleotide level, and the previously characterized sequence from Turkey (KE.4) were also included. Substitutions detected in the study are in italics and bold. Positions with identical residues in all strains are excluded. Amino acids not covered by the available sequences are shown as blank (dashes).
A, alanine; C, cysteine; D, aspartic acid; E, glutamic acid; F, phenylalanine; G, glycine; H, histidine; I, isoleucine; K, lysine; N, asparagine; P, proline; S, serine; T, threonine; V, valine; Y, tyrosine.